These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 33994322)

  • 21. The great escape? SARS-CoV-2 variants evading neutralizing responses.
    Prévost J; Finzi A
    Cell Host Microbe; 2021 Mar; 29(3):322-324. PubMed ID: 33705702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants.
    Massacci A; Sperandio E; D'Ambrosio L; Maffei M; Palombo F; Aurisicchio L; Ciliberto G; Pallocca M
    J Transl Med; 2020 Dec; 18(1):494. PubMed ID: 33380328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.
    Singh Y; Fuloria NK; Fuloria S; Subramaniyan V; Meenakshi DU; Chakravarthi S; Kumari U; Joshi N; Gupta G
    J Med Virol; 2021 Oct; 93(10):5726-5728. PubMed ID: 34232521
    [No Abstract]   [Full Text] [Related]  

  • 24. Startling new variant raises urgent questions.
    Kupferschmidt K
    Science; 2021 Dec; 374(6572):1178-1180. PubMed ID: 34855503
    [No Abstract]   [Full Text] [Related]  

  • 25. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron.
    Carreño JM; Alshammary H; Tcheou J; Singh G; Raskin AJ; Kawabata H; Sominsky LA; Clark JJ; Adelsberg DC; Bielak DA; Gonzalez-Reiche AS; Dambrauskas N; Vigdorovich V; ; Srivastava K; Sather DN; Sordillo EM; Bajic G; van Bakel H; Simon V; Krammer F
    Nature; 2022 Feb; 602(7898):682-688. PubMed ID: 35016197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 variants, spike mutations and immune escape.
    Harvey WT; Carabelli AM; Jackson B; Gupta RK; Thomson EC; Harrison EM; Ludden C; Reeve R; Rambaut A; ; Peacock SJ; Robertson DL
    Nat Rev Microbiol; 2021 Jul; 19(7):409-424. PubMed ID: 34075212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs.
    Thura M; Sng JXE; Ang KH; Li J; Gupta A; Hong JM; Hong CW; Zeng Q
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34519332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing Activity of BNT162b2-Elicited Serum.
    Liu Y; Liu J; Xia H; Zhang X; Fontes-Garfias CR; Swanson KA; Cai H; Sarkar R; Chen W; Cutler M; Cooper D; Weaver SC; Muik A; Sahin U; Jansen KU; Xie X; Dormitzer PR; Shi PY
    N Engl J Med; 2021 Apr; 384(15):1466-1468. PubMed ID: 33684280
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.
    Wu K; Werner AP; Koch M; Choi A; Narayanan E; Stewart-Jones GBE; Colpitts T; Bennett H; Boyoglu-Barnum S; Shi W; Moliva JI; Sullivan NJ; Graham BS; Carfi A; Corbett KS; Seder RA; Edwards DK
    N Engl J Med; 2021 Apr; 384(15):1468-1470. PubMed ID: 33730471
    [No Abstract]   [Full Text] [Related]  

  • 30. Neutralizing SARS-CoV-2.
    Poeschla E
    Elife; 2020 Dec; 9():. PubMed ID: 33320086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omicron's lasting mysteries: four questions scientists are racing to answer.
    Dance A
    Nature; 2022 Mar; 603(7899):22-24. PubMed ID: 35210605
    [No Abstract]   [Full Text] [Related]  

  • 32. COVID-19 Vaccines Based on Adenovirus Vectors.
    Hasanpourghadi M; Novikov M; Ertl HCJ
    Trends Biochem Sci; 2021 May; 46(5):429-430. PubMed ID: 33810926
    [No Abstract]   [Full Text] [Related]  

  • 33. Omicron likely to weaken COVID vaccine protection.
    Callaway E
    Nature; 2021 Dec; 600(7889):367-368. PubMed ID: 34880488
    [No Abstract]   [Full Text] [Related]  

  • 34. A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine.
    Hörner C; Schürmann C; Auste A; Ebenig A; Muraleedharan S; Dinnon KH; Scholz T; Herrmann M; Schnierle BS; Baric RS; Mühlebach MD
    Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32657-32666. PubMed ID: 33257540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants.
    Lin WS; Chen IC; Chen HC; Lee YC; Wu SC
    Front Immunol; 2021; 12():795741. PubMed ID: 34925381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
    Wang Z; Schmidt F; Weisblum Y; Muecksch F; Barnes CO; Finkin S; Schaefer-Babajew D; Cipolla M; Gaebler C; Lieberman JA; Oliveira TY; Yang Z; Abernathy ME; Huey-Tubman KE; Hurley A; Turroja M; West KA; Gordon K; Millard KG; Ramos V; Da Silva J; Xu J; Colbert RA; Patel R; Dizon J; Unson-O'Brien C; Shimeliovich I; Gazumyan A; Caskey M; Bjorkman PJ; Casellas R; Hatziioannou T; Bieniasz PD; Nussenzweig MC
    Nature; 2021 Apr; 592(7855):616-622. PubMed ID: 33567448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novavax offers first evidence that COVID vaccines protect people against variants.
    Callaway E; Mallapaty S
    Nature; 2021 Feb; 590(7844):17. PubMed ID: 33510489
    [No Abstract]   [Full Text] [Related]  

  • 38. RBD Double Mutations of SARS-CoV-2 Strains Increase Transmissibility through Enhanced Interaction between RBD and ACE2 Receptor.
    Sinha S; Tam B; Wang SM
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What the Omicron wave is revealing about human immunity.
    Willyard C
    Nature; 2022 Feb; 602(7895):22-25. PubMed ID: 35110764
    [No Abstract]   [Full Text] [Related]  

  • 40. Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion.
    Salleh MZ; Derrick JP; Deris ZZ
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.